News

CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid, and GSK announced the publication of preclinical data investigating immune responses as well as the protective efficacy of CureVac’s first-generation vaccine...

Gritstone bio, Inc., a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, announced that the company entered into a funding agreement of up to $20.6 million with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance...

Exelixis and Invenra have extended their discovery and licensing partnership to include 20 more oncology targets for multi-specific antibodies, antibody-drug conjugates, and the development of other biologic candidates. In May 2018, the companies collaborated to discover and develop mono-specific and...

Etihad Cargo, the cargo and logistics arm of Abu Dhabi’s Etihad Aviation Group, has reclaimed 90 per cent of its pre-COVID destinations and recorded a 20% increase in tonnage compared to the same period in 2019. The award-winning UAE carrier,...

Chinese pharmaceutical giant Sinopharm has signed an agreement with Bangladesh over the co-production of COVID-19 inactivated vaccines.  Five million vaccines will be finished and dispensed monthly in the Bangladeshi capital Dhaka if everything goes to plan. The chairman of Sinopharm,...

CloudWorks4All, a leading cloud enterprise resource planning (ERP) systems integrator, has been contracted by MabPlex USA, Inc. to implement the top cloud ERP solution, SAP® Business ByDesign®, to further advance the company’s abilities to grow its North American operations. “We...

An end-to-end solution could simply be described as a completely functional solution delivering a self-contained system, service or process stage from beginning to end. Within a fully integrated solution individual components are typically sourced, and managed, through a single...